DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 51 filers reported holding DYNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,511,180 | -49.4% | 478,401 | -49.1% | 0.10% | -57.4% |
Q4 2022 | $10,890,520 | -14.2% | 939,648 | -6.0% | 0.23% | -31.1% |
Q3 2022 | $12,700,000 | +84.9% | 1,000,000 | 0.0% | 0.33% | +127.2% |
Q2 2022 | $6,870,000 | -28.7% | 1,000,000 | 0.0% | 0.15% | -26.9% |
Q1 2022 | $9,640,000 | -18.9% | 1,000,000 | 0.0% | 0.20% | +9.2% |
Q4 2021 | $11,890,000 | -26.8% | 1,000,000 | 0.0% | 0.18% | -13.2% |
Q3 2021 | $16,240,000 | -22.8% | 1,000,000 | 0.0% | 0.21% | -2.3% |
Q2 2021 | $21,040,000 | +35.5% | 1,000,000 | 0.0% | 0.22% | +41.8% |
Q1 2021 | $15,530,000 | +23.3% | 1,000,000 | +66.7% | 0.15% | +53.0% |
Q4 2020 | $12,600,000 | +4.0% | 600,000 | 0.0% | 0.10% | +8.7% |
Q3 2020 | $12,114,000 | – | 600,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |